Clinical Trials Directory

Trials / Conditions / Metastatic Cervical Carcinoma

Metastatic Cervical Carcinoma

11 registered clinical trials studyying Metastatic Cervical Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
WithdrawnSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Col
NCT06626256
City of Hope Medical CenterPhase 1
RecruitingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
Mayo Clinic—
Active Not RecruitingDostarlimab and Cobolimab in Advanced Cervical Cancer
NCT06238635
Meghan SheaPhase 2
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
UnknownTislelizumab and Radiotherapy for Recurrent Cervical Cancer
NCT05310383
Lei LiPhase 2
UnknownDonafenib for Recurrent Cervical Cancer
NCT05310331
Lei LiPhase 2
UnknownPD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
NCT05310305
Lei Li—
Active Not RecruitingHuman Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635
Mayo Clinic—
SuspendedPaclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555
Wake Forest University Health Sciences—
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With
NCT03508570
M.D. Anderson Cancer CenterPhase 1
CompletedStereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Me
NCT03452332
M.D. Anderson Cancer CenterPhase 1